IPOPLUS

1,106.9

+4.2 +0.38%

17 Jun 2026

NSE Listed · Pharmaceuticals

Strides Pharma Sci Ltd. (STAR)

Volume: 7,276Avg Vol 1W: 10,616Avg Vol 1M: 14,16252W Range:768.651,231
₹1,106.9 0.38%
Key Ratios
Updated 1h ago
Market Cap₹9,718 Cr
Current Price₹1,106.9
Previous Close₹1,102.7
High / Low (52w)₹1,231 / ₹768.65
Volume7,276
Avg Vol (1W)10,616
Avg Vol (1M)14,162
Stock P/E1.72
Book Value₹337.16
Dividend Yield0.47%
ROE17.9%
ROA8.29%
Revenue (TTM)
Revenue Growth17.36%
Profit Margin11.45%
Total Debt₹571 Cr
Shares Outstanding9 Cr
Face Value₹10
EPS (TTM)₹13.77
P/B3.43
Debt / Equity0.57
50 DMA₹1,092.1
200 DMA₹949.69
Day change+0.38%
Price Chart
1,106.9 35.48% · 1Y
118979292.2L
2025-10-01
2026-06-16

20-day avg volume: 12K shares

Pros
  • Healthy return on equity of 17.9%.
  • Company is almost debt-free.
  • Revenue grew 18% YoY.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹1,323 Cr₹1,195 Cr₹1,221 Cr₹1,120 Cr₹1,190 Cr₹1,154 Cr₹1,167 Cr₹1,054 Cr₹1,044 Cr₹1,006 Cr₹999 Cr₹930 Cr₹986 Cr₹865 Cr₹897 Cr₹940 Cr₹866 Cr₹794 Cr₹721 Cr₹688 Cr₹908 Cr₹832 Cr₹794 Cr₹782 Cr₹619 Cr
EBITDA₹195 Cr₹292 Cr₹209 Cr₹178 Cr₹181 Cr₹168 Cr₹165 Cr₹156 Cr₹143 Cr₹101 Cr₹129 Cr₹116 Cr₹122 Cr₹82 Cr₹60 Cr₹13 Cr₹68 Cr₹-49 Cr₹-48 Cr₹-92 Cr₹118 Cr₹121 Cr₹122 Cr₹118 Cr₹37 Cr
Net Profit₹127 Cr₹202 Cr₹128 Cr₹100 Cr₹82 Cr₹88 Cr₹72 Cr₹3,351 Cr₹18 Cr₹50 Cr₹-131 Cr₹-7 Cr₹-10 Cr₹-80 Cr₹23 Cr₹-136 Cr₹29 Cr₹-122 Cr₹-163 Cr₹-205 Cr₹46 Cr₹38 Cr₹81 Cr₹104 Cr₹-204 Cr
EPS13.7721.9213.8410.818.929.557.8363.961.985.42-14.54-0.79-1.06-8.862.54-15.133.25-13.55-18.12-22.885.144.229.0311.56-22.76
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹4,624 Cr₹3,930 Cr₹3,779 Cr₹3,202 Cr₹3,367 Cr₹2,805 Cr
EBITDA₹669 Cr₹408 Cr₹277 Cr₹-121 Cr₹480 Cr₹395 Cr
Net Profit₹3,593 Cr₹-71 Cr₹-203 Cr₹-460 Cr₹268 Cr₹36 Cr
EPS390.5-7.76-22.49-51.2829.924.06
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹6,049 Cr₹5,840 Cr₹6,638 Cr₹6,976 Cr₹7,015 Cr₹6,152 Cr
Total Liabilities₹3,462 Cr₹3,768 Cr₹4,466 Cr₹4,593 Cr₹4,201 Cr₹3,557 Cr
Equity₹2,586 Cr₹2,072 Cr₹2,173 Cr₹2,383 Cr₹2,814 Cr₹2,595 Cr
Total Debt₹571 Cr₹671 Cr₹1,140 Cr₹836 Cr₹883 Cr₹604 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹617 Cr₹677 Cr₹-43 Cr₹-260 Cr₹325 Cr₹250 Cr
Investing₹-90 Cr₹-150 Cr₹302 Cr₹-119 Cr₹-521 Cr₹1,306 Cr
Financing₹-643 Cr₹-693 Cr₹-214 Cr₹421 Cr₹-16 Cr₹-1,709 Cr
Free Cash Flow₹375 Cr₹559 Cr₹-138 Cr₹-404 Cr₹27 Cr₹100 Cr
Shareholding
Promoter 27.91% Institutions 43.13% Public 28.95%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search